More recently, combined detection of urinary prostate cancer gene 3 (PCA3) and TMPRSS2:ERG has been shown to improve the sensitivity for prostate cancer diagnosis (Robert et al., 2013). The gene discussed is ERG; the disease is prostate carcinoma.